After grabbing 0.88 million shares, the institutional investor is now in possession of 0.88 million shares of the Consumer Cyclical Company. The new investment brought the stake of investor firm to 3.02% having worth around $16.93 million. Moreover, Columbia Management Investment Ad.. increased its share by 0.69 million to have a control over 0.69 million shares. And Driehaus Capital Management LLC raised its holdings to 0.61 million shares by acquiring 0.61 million shares or 2.10% of the stake.
GAN Limited (GAN) concluded trading on 08/26/20 at a closing price of $21.33, with 1.13 million shares of worth about $24.0 million changed hands on the day. Weekly performance of the stock remained negative as price took a plunge of -12.80% during that period and on Wednesday the price saw a gain of about 2.80%. Currently the company’s common shares owned by public are about 28.93M shares, out of which, 21.84M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 4 analysts are covering the GAN stock and their offered price forecasts bring an average price target of $28.63. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $30.00 and could fall to a lowest price of $28.00. Analysts also issued an outlook of 2.00 for the GAN Limited stock for next 12 months. The stock’s current price level is 26.14% above of average price target set by the analysts, while a rise to estimated low would result in gain of 23.82 for the stock. However, touching the estimated high of $30.00 would mean a gain of 28.9% for the stock.
Columbia Small Cap Growth Fund I, Heptagon Fund Plc – Driehaus US M, and Davenport Small Cap Focus Fund are the top 3 mutual funds which are holding stakes in GAN Limited Columbia Small Cap Growth Fund I is currently holding 0.49 million shares of worth totaling $9.52 million. The company recently came buying 0.49 million shares which brought its stake up to 1.70% of the company’s outstanding shares. Davenport Small Cap Focus Fund, after buying 0.26 million shares, have now control over 0.91% of the stake in the company. It holds 0.11 million shares of worth $5.11 million.
GAN Limited (NASDAQ: GAN) started trading at $20.68, below -$0.07 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $21.33, or with a gain of 2.80%. Stock saw a price change of -12.80% in past 5 days and over the past one month there was a price change of 0.38%. Over the period of past 52 weeks, stock dropped to lowest price of $2.60 but also hit the highest price of $28.95 during that period. While comparing its average daily trading volume of 2.11 million shares, we see that about 1.13 million changed hands on the day. The stock is currently trading 0.14% above its 20-day simple moving average (SMA20), while that difference is down -8.57% for SMA50 and it goes to 70.76% higher than SMA200.
Robotti & Co. Advisors LLC acquired 0.88 million shares of GAN Limited having value of about $16.93 million. GAN Limited (NASDAQ: GAN) currently have 28.93M outstanding shares and institutions hold larger chunk of about 31.94% of that. Holding of mutual funds in the company is about 13.07% while other institutional holders and individual stake holders have control over 22.96% and — of the stake respectively.
The stock has a current market capitalization of $617.10M. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GAN, volatility over the week remained 7.64% while standing at 6.99% over the month.
Analysts are in expectations that GAN Limited (GAN) stock would likely to be making an EPS of $0.02 in the current quarter, while forecast for next quarter ESPS is $0.06 and it is $0.17 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.01 which is $0.04 at the higher side of the target for the same.
Analysts at 4 brokerage firms have issued recommendations for the GAN Limited (GAN)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 4 Wall Street analysts, 4 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Northland Capital on July 17, 2020 offering an Outperform rating for the stock and assigned a target price of to it. Coverage by Macquarie stated GAN Limited (GAN) stock as an Outperform in their note to investors on June 04, 2020, suggesting a price target of $24 for the stock.